Finance & Supply Chain Analyst – Romanian Cluster (Adriatics, Romania, Bulgaria, Serbia) at Eli Lilly and Company

Ljubljana, Ljubljana, Slovenia

Apply Now

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree in Finance, Accounting, Economics, Business Administration, or related field
3-5 years of relevant experience in financial analysis, supply chain, or business analysis
Experience in multinational or fast-paced environments is a plus
Familiarity with financial systems and tools (Excel, PowerPoint; SAP or Power BI is a plus)
Solid understanding of demand planning and inventory management concepts
Interest in leveraging technology and automation to improve processes
Strong analytical and problem-solving skills with a detail-oriented mindset
Excellent communication and interpersonal skills
Ability to manage ambiguity and operate under pressure
Strong organizational skills, with the ability to prioritize effectively

Responsibilities

Support short, mid, and long-term forecasting processes for sales, OPEX, and other financial areas
Prepare relevant reporting (quantitative & qualitative) for the cluster business
Provide financial analytics to support decision-making and business initiatives
Gather market data, competitor intelligence, and business insights for the portfolio
Assist with demand planning (S&OP) and forecast updates in collaboration with Sales and Marketing
Support inventory management, including reviews of slow-moving and obsolete stock, and help validate cycle counts at warehouses
Ensure compliance with financial policies and procedures; assist with monthly and quarterly closing activities
Help maintain internal controls and support compliance audits
Support local distribution governance and logistics/supply chain projects
Gather market intelligence for distribution markets
Act as a liaison between distribution channels, shared services (GBS), and internal teams to streamline O2C activities
Monitor order management processes to ensure efficient operations and timely revenue recognition
Help oversee master data management, ensuring accuracy in customer, price, and material records within SAP
Assist with system readiness for new product launches and ensure timely product supply to markets
Support process-related controls and adherence to internal policies
Provide financial and supply chain support to the Cluster CFO and affiliate Finance Managers, as well as cross-functional leaders
Help streamline financial and supply chain processes to enhance productivity

Skills

Financial Planning

Financial Analysis

Forecasting

Reporting

Supply Chain Management

Demand Planning

S&OP

Inventory Management

Market Analysis

Competitor Intelligence

Excel

Analytics

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free